Gregory Challener, MD

Massachusetts General Hospital
Boston, Massachusetts, United States

Rheumatologist and clinician investigator at MGH with an interest in rheumatic complications of immune checkpoint inhibitors and novel applications of GLP-1 RAs and SGLT2is in gout and other forms of arthritis.

Presentation(s):

• 0344: Inpatient Zoledronic Acid for Glucocorticoid-Induced Osteoporosis Prevention

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.

• 0813: Impact of Tirzepatide on Musculoskeletal Pain and High-Risk Analgesic Use Among Non-Diabetic Patients with Overweight or Obesity: A Propensity Score-Matched, Active Comparator, New User Study

  Sunday, October 26, 2025
  3:00 PM - 3:15 PM Central Time

  Disclosure information not submitted.

• 1100: Associations Between Pre-existing Autoimmunity and CAR T Cell Therapy Toxicity for Cancer Treatment: A Nationwide Retrospective Cohort Study

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.